|
Have you received a letter from the DEA stating you need to complete 8 hours of training on the treatment and management of patients with opioid or other substance use disorders? The deadline for satisfying this new training requirement is the date of your next scheduled DEA registration submission on or after June 27, 2023.
The Medication Access and Training Expansion (MATE) Act standardizes substance use disorder training to ensure that all prescribers of addictive medications possess baseline knowledge in evidence-based addiction prevention and treatments.
1) The new training requirement under the MATE Act is only for prescribers with a DEA license that allows them to prescribe controlled substances under schedules II, III, IV, or V.
2) This new requirement begins June 21, 2023. This will be for all new applications and first renewal cycle after this date.
3) This does not affect any license renewals between now and June 21, 2023.
4) Additionally, the MAT Act (MAT Act: Removes the waiver requirement to prescribe buprenorphine for opioid use disorder) has eliminated the X-Waiver program. This was effective immediately in December 2022. The June 8th webinar (see below) will cover the details of these changes.
5) There is no new training requirement for prescribers who do not have a DEA number.
| 
